Rochester Licenses First-in-Class Anti-Leukemia Drug to Panther Biotechnology
Rochester Licenses First-in-Class Anti-Leukemia Drug to Panther Biotechnology
in
17 April 2015 CNN Money Panther Biotechnology, Inc. (OTC PINK: PBYA), a biotechnology company specializing in the development of enhanced therapeutics for the treatment of neoplastic disorders, is pleased to announce today that it has entered into an exclusive global license agreement with the University